Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD
Clinical trial NCT03247556 · COMPLETED
Trial details
- NCT number
- NCT03247556
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-20
- Primary completion
- 2019-02-14
- Enrollment
- 297
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.